Miguel Martin (M Pollán, Miguel Martín, M Martín)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 71

Top Topics

Early Breast Cancer

Epidermal Growth Factor Receptor

Circulating Tumor

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martin
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martin
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer treated with anthracycline-free neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Miguel Martin, Joo Hyuk Sohn
Reply to A. Okeya et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martin
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martin
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Olga Martínez-Sáez, Javier Cortés, Eva Ciruelos, Mercedes Marín-Aguilera, Gloria González, Laia Paré, Adriana Herrera, Patricia Villagrasa-González, Aleix Prat, Miguel Martin
Management of early-stage HER2-positive breast cancer and attitudes towards HER2DX test in Spain: insights from a nationwide survey. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Miguel Martin, Elgene Lim, Mariana Chavez Mac Gregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, Rustem Safin, Sung-Bae Kim, Christian Schem, Alberto J Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Diego Pérez-Moreno, Joo Hyuk Sohn, null null
Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (18) (2024)
Rodrigo Sánchez-Bayona, Alfonso Lopez de Sa, Yolanda Jerez Gilarranz, Ana Sanchez de Torre, Manuel Alva, Isabel Echavarria, Fernando Moreno, Pablo Tolosa, Blanca Herrero Lopez, Alicia de Luna, Laura Lema, Salvador Gamez Casado, Ainhoa Madariaga, Sara López-Tarruella, Luis Manso, Coralia Bueno-Muiño, Jose A Garcia-Saenz, Eva Ciruelos, Miguel Martin
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort. Breast cancer research and treatment 206 (3) (2024)
Dennis J Slamon, Véronique Diéras, Hope S Rugo, Nadia Harbeck, Seock-Ah Im, Karen A Gelmon, Oleg N Lipatov, Janice M Walshe, Miguel Martin, Mariana Chavez Mac Gregor, Eustratios Bananis, Eric Gauthier, Dongrui Ray Lu, Sindy Kim, Richard S Finn
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober, Valentina Guarneri, Stephen R D Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S Rugo, Joyce O'Shaughnessy
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ breast cancer 10 (1) (2024)
Miguel Martin, Rachel Yoder, Roberto Salgado, Maria Del Monte-Millán, Enrique L Álvarez, Isabel Echavarría, Joshua M Staley, Anne P O'Dea, Lauren E Nye, Shane R Stecklein, Coralia Bueno, Yolanda Jerez, María Cebollero, Oscar Bueno, José Angel García-Saenz, Fernando Moreno Antón, Uriel Bohn, Henry L Gómez, Tatiana Massarrah, Qamar J Khan, Andrew K Godwin, Miguel Martín, Priyanka Sharma
Tumor-infiltrating lymphocytes refine outcomes in triple-negative breast cancer treated with anthracycline-free neoadjuvant chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rodrigo Sánchez-Bayona, Alfonso Lopez de Sa, Yolanda Jerez Gilarranz, Ana Sanchez de Torre, Manuel Alva, Isabel Echavarria, Fernando Moreno, Pablo Tolosa, Blanca Herrero Lopez, Alicia de Luna, Laura Lema, Salvador Gamez Casado, Ainhoa Madariaga, Sara López-Tarruella, Luis Manso, Coralia Bueno-Muiño, Jose A Garcia-Saenz, Eva Ciruelos, Miguel Martin
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2- advanced breast cancer: a real-world evidence cohort. Breast cancer research and treatment (2024)
Matthew P Goetz, Irfan Cicin, Laura Testa, Sara M Tolaney, Jens Huober, Valentina Guarneri, Stephen R D Johnston, Miguel Martin, Priya Rastogi, Nadia Harbeck, Ashwin Shahir, Ran Wei, Valérie André, Hope S Rugo, Joyce O'Shaughnessy
Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study. NPJ breast cancer 10 (1) (2024)
Angel L Guerrero-Zotano, Stefania Belli, Christoph C Zielinski, Juan Miguel Gil-Gil, Antonio Fernandez-Serra, Manuel Ruiz Borrego, Eva Ciruelos Gil, Javier Pascual, Montserrat Muñoz, Begoña Bermejo, Mireia Margelí, Antonio Antón-Torres, Laura Murillo, Bella Nisenbaum, Yuan Liu, Jesus Herranz, Daniel Fernandez-Garcia, Rosalía Caballero, Jose Antonio Lopez-Guerrero, Roberto Bianco, Luigi Formisano, Nicholas C Turner, Miguel Martin
CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Antonio Calles, Marta Arregui, Julia Suárez-González, María García-Martos, Ivan Marquez-Rodas, Rosa Álvarez, Miguel Martin
Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report. JCO precision oncology 7 (2023)
Javier Pascual, Juan Miguel Gil-Gil, Paula Z Proszek, Christoph C Zielinski, Alistair Reay, Manuel Ruiz Borrego, Rosalind J Cutts, Eva Ciruelos Gil, Andrew Feber, Montserrat Muñoz, Claire Swift, Begoña Bermejo, Jesus Herranz, Mireia Margelí, Antonio Antón-Torres, Zsuzsanna Kahán, Tibor Csőszi, Yuan Liu, Daniel Fernandez-Garcia, Isaac Garcia-Murillas, Michael Hubank, Nicholas C Turner, Miguel Martin
Baseline mutations and ctDNA dynamics as prognostic and predictive factors in ER-positive/HER2-negative metastatic breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Miguel Martin, Eva Carrasco, Álvaro Rodríguez-Lescure, Raquel Andrés, Sonia Servitja, Antonio Antón, Manuel Ruiz-Borrego, Begoña Bermejo, Ángel Guerrero, Manuel Ramos, Ana Santaballa, Montserrat Muñoz, Josefina Cruz, Sara Lopez-Tarruella, Jose I Chacón, Isabel Álvarez, Purificación Martínez, Juan J Miralles, Óscar Polonio, Carlos Jara, David Aguiar-Bujanda
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry. Breast cancer research and treatment (2023)
Matthew P Goetz, Erika Paige Hamilton, Mario Campone, Sara Alsterlind Hurvitz, Javier Cortes, Stephen R D Johnston, Antonio Llombart, Peter A Kaufman, Masakazu Toi, Guy Jerusalem, Hillary Graham, Hong Wang, Valerie M Jansen, Lacey M Litchfield, Miguel Martin
Landscape of baseline and acquired genomic alterations in circulating tumor DNA with abemaciclib alone or with endocrine therapy in advanced breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Aurora Gómez-Vecino, Roberto Corchado-Cobos, Adrián Blanco-Gómez, Natalia García-Sancha, Sonia Castillo-Lluva, Ana Martín-García, Marina Mendiburu-Eliçabe, Carlos Prieto, Sara Ruiz-Pinto, Guillermo Pita, Alejandro Velasco-Ruiz, María Carmen Patino-Alonso, M Purificación Galindo-Villardón, María Linarejos Vera-Pedrosa, Jose Jalife, Jian-Hua Mao, Guillermo Macías de Plasencia, Andrés Castellanos-Martín, María Del Mar Sáez-Freire, Susana Fraile-Martín, Telmo Rodrigues-Teixeira, Carmen García-Macías, Julie Milena Galvis-Jiménez, Asunción García-Sánchez, María Isidoro-García, Manuel Fuentes, Maria-Begoña Garcia-Cenador, Francisco Javier García-Criado, Juan Luis García Hernández, María Ángeles Hernández-García, Juan Jesús Cruz Hernández, César Augusto Rodríguez-Sánchez, Alejandro Martin Martin Garcia-Sancho, Estefanía Pérez-López, Pérez-Martínez Antonio, Federico Gutiérrez-Larraya, Antonio J Cartón, José Angel García-Saenz, Ana Patiño-García, Miguel Martin, Teresa Alonso-Gordoa, Christof Vulsteke, Lieselot Croes, Sigrid Hatse, Thomas Van Brussel, Diether Lambrechts, Hans P M W Wildiers, Hang Chang, Marina Holgado-Madruga, Anna González-Neira, Pedro Luis Sánchez, Jesús Pérez Losada
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. Cells 12 (15) (2023)
Sara Lopez-Tarruella, María Del Monte-Millán, Marta Roche-Molina, Yolanda Jerez, Isabel Echavarria Diaz-Guardamino, Blanca Herrero López, Salvador Gamez Casado, Iván Marquez-Rodas, Enrique Alvarez, María Cebollero, Tatiana Massarrah, Inmaculada Ocaña, Ainhoa Arias, José Ángel García-Sáenz, Fernando Moreno Anton, Clara Olier Garate, Diana Moreno Muñoz, David Marrupe, Miguel Ángel Lara Álvarez, Santos Enrech, Coralia Bueno Muiño, Miguel Martin
Correlation between breast cancer subtypes determined by immunohistochemistry and n-COUNTER PAM50 assay: a real-world study. Breast cancer research and treatment (2023)
Pfeiler Georg, Dominik Hlauschek, Erica L Mayer, Christine Deutschmann, Stephanie Kacerovsky-Strobl, Miguel Martin, Jane Lowe Meisel, Nicholas Zdenkowski, Sibylle Loibl, Marija Balić, Haeseong Park, Aleix Prat, Claudine Isaacs, Emilio Bajetta, Justin M Balko, Merixtell Bellet-Ezquerra, Judith M Bliss, Harold J Burstein, Fatima Cardoso, Hannes Fohler, Theodoros Foukakis, Karen A Gelmon, Matthew P Goetz, Tufia C Haddad, Hiroji Iwata, Jacek Jassem, Soo-Chin Lee, Barbro Linderholm, Maartje Los, Eleftherios P P Mamounas, Kathy D Miller, Patrick G Morris, Elisabetta Munzone, Einav Nili Gal-Yam, Alistair Ring, Lois E Shepherd, Christian F Singer, Christoph Thomssen, Ling Ming Tseng, Pinuccia Valagussa, Eric P Winer, Antonio C Wolff, Francesco Ravera, Jana Machacek-Link, Céline Schurmans, Xin Huang, Eric Gauthier, Christian Fesl, Amylou C Dueck, Angela M DeMichele, Michael Gnant, null null
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Joanne L Blum, A Douglas Laird, Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Miguel Martin, Henri H Roché, Kyung-Hun Lee, Annabel Goodwin, Ying Chen, Silvana Lanzalone, Jijumon Chelliserry, Akos Czibere, Julia F Hopkins, Lee A Albacker, Lida A Mina
Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Matteo Duca, Darren Wan-Teck Lim, Vivek Subbiah, Shunji Takahashi, John Sarantopoulos, Andrea Varga, Joseph A D'Alessio, Tinya Abrams, Qing Sheng, Eugene Youchin Tan, Maria Santos Rosa, Juan Gonzalez-Maffe, Janna Sand-Dejmek, Claire Fabre, Miguel Martin
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors. Molecular cancer therapeutics 21 (4) (2022)
Karama Asleh, Ana Lluch, Angela Goytain, Carlos Henrique Barrios, Xue Qi Wang, Laura Torrecillas, Dongxia Gao, Manuel Ruiz Borrego, Samuel C Y Leung, Jose Bines, Angel L Guerrero-Zotano, José Angel García-Saenz, Juan Miguel Cejalvo, Jesus Herranz, Roberto Torres, Juan R De la Haba-Rodríguez, Francisco Ayala, Henry L Gómez, Federico Rojo, Torsten O Nielsen, Miguel Martin
Triple negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Parvin F Peddi, Peter Andreas Fasching, Duan Liu, Emmanuel Quinaux, Nicholas J Robert, Vicente Valero, John Crown, Carla I Falkson, Adam M Brufsky, Julie M Cunningham, Richard M Weinshilboum, Tadeusz Pienkowski, Wolfgang Eiermann, Miguel Martin, Valerie Bee, Xiaoyan Wang, Liewei Wang, Eric H Yang, Dennis J Slamon, Sara A Hurvitz
Genetic Polymorphisms and Correlation with Treatment-Induced Cardiotoxicity and Prognosis in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
Coralia Bueno Muiño, Miguel Martin, María Del Monte-Millán, José Angel García-Saenz, Miguel Martín
HER2+ Breast Cancer Escalation and De-Escalation Trial Design: Potential Role of Intrinsic Subtyping. Cancers 14 (3) (2022)
Miguel Martín, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Salvador Gamez, Miguel Martin
How we treat HR-positive, HER2-negative early breast cancer. Future oncology (London, England) 18 (8) (2022)
Carolina Donat-Vargas, Ángel Guerrero-Zotano, Ana Casas, José Manuel Baena-Cañada, Virginia Lope, Silvia Antolín, José Ángel Garcia-Saénz, Begoña Bermejo, Montserrat Muñoz, Manuel Ramos, Ana de Juan, Carlos Jara Sánchez, Pedro Sánchez-Rovira, Antonio Antón, Joan Brunet, Joaquín Gavilá, Javier Salvador, Esperanza Arriola Arellano, Susana Bezares, Nerea Fernández de Larrea-Baz, Beatriz Perez-Gomez, Miguel Martin, Marina Pollán
Trajectories of alcohol consumption during life and the risk of developing breast cancer. British journal of cancer 125 (8) (2021)
Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García Alfonso, José Luis Revuelta-Herrero, Fabienne Thomas, Sara López-Tarruella, Xandra García, Aitana Calvo, Malika Yakoubi, Sara Salvador-Martín, Flora López-López, Iker Aguilar, María Sanjurjo-Sáez, Miguel Martin, Luis Andrés López-Fernández
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach. Journal of personalized medicine 11 (8) (2021)
Sibylle Loibl, Frederic Marmé, Miguel Martin, Michael Untch, Hervé R Bonnefoi, Sung-Bae Kim, Harry Bear, Nicole McCarthy, Mireia Melé Olivé, Karen Gelmon, José García-Sáenz, Catherine M Kelly, Toralf Reimer, Masakazu Toi, Hope S Rugo, Carsten Denkert, Michael Gnant, Andreas Makris, Maria Koehler, Cynthia Huang-Bartelett, Maria Jose Lechuga Frean, Marco Colleoni, Gustavo Werutsky, Sabine Seiler, Nicole Burchardi, Valentina Nekljudova, Gunter von Minckwitz
Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Michael Gnant, Amylou C Dueck, Sophie Frantal, Miguel Martin, Hal J Burstein, Richard Greil, Peter Fox, Antonio C Wolff, Arlene Chan, Eric P Winer, Georg Pfeiler, Kathy D Miller, Marco Colleoni, Jennifer M Suga, Gabor Rubovszky, Judith M Bliss, Ingrid A Mayer, Christian F Singer, Zbigniew Nowecki, Olwen Hahn, Jacqui Thomson, Norman Wolmark, Kepa Amillano, Hope S Rugo, Guenther G Steger, Blanca Hernando Fernández de Aránguiz, Tufia C Haddad, Antonia Perelló, Meritxell Bellet, Hannes Fohler, Otto Metzger Filho, Anita Jallitsch-Halper, Kadine Solomon, Céline Schurmans, Kathy P Theall, Dongrui Ray Lu, Kathleen Tenner, Christian Fesl, Angela M DeMichele, Erica L Mayer, null null
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Kevin Kalinsky, William E Barlow, Julie R Gralow, Funda Meric-Bernstam, Kathy S Albain, Daniel F Hayes, Nancy U Lin, Edith A Perez, Lori J Goldstein, Stephen K L Chia, Sukhbinder Dhesy-Thind, Priya Rastogi, Emilio Alba, Suzette Delaloge, Miguel Martin, Catherine M Kelly, Manuel Ruiz-Borrego, Miguel Gil-Gil, Claudia H Arce-Salinas, Etienne G C Brain, Eun-Sook Lee, Jean-Yves Pierga, Begoña Bermejo, Manuel Ramos-Vazquez, Kyung-Hae Jung, Jean-Marc Ferrero, Anne F Schott, Steven Shak, Priyanka Sharma, Danika L Lew, Jieling Miao, Debasish Tripathy, Lajos Pusztai, Gabriel N Hortobagyi
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. The New England journal of medicine 385 (25) (2021)
Francesco Schettini, Mario Giuliano, Matteo Lambertini, Rupert Bartsch, David James Pinato, Concetta Elisa Onesti, Nadia Harbeck, Diana Lüftner, Sylvie Rottey, Peter A van Dam, Khalil Zaman, Giorgio Mustacchi, Joseph Gligorov, Ahmad Awada, Mario Campone, Hans P M W Wildiers, Alessandra Gennari, Vivianne C G Tjan-Heijnen, Javier Cortes, Mariavittoria Locci, Ida Paris, Lucia Del Mastro, Sabino De Placido, Miguel Martin, Guy Jerusalem, Sergio Venturini, Curigliano Giuseppe, Daniele Generali
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer. Cancers 13 (17) (2021)
Stephen R D Johnston, Nadia Harbeck, Masakazu Toi, Miguel Martin, Joyce O'Shaughnessy, Priya Rastogi
Reply to K. Hashimoto and A. Shimomura. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (13) (2021)
Rocío Ramos-Medina, Miguel Martín, María Del Monte-Millán, Tatiana Massarrah, Miguel Martin
Technical Challenges for CTC Implementation in Breast Cancer. Cancers 13 (18) (2021)
Nerea Fernández de Larrea-Baz, Beatriz Perez-Gomez, Ángel Guerrero-Zotano, Ana María Casas, Begoña Bermejo, José Manuel Baena-Cañada, Silvia Antolin, Pedro Sánchez-Rovira, Manuel Ramos Vázquez, José Angel García-Saenz, Antonio Antón, Montserrat Muñoz, Ana de Juan, Carlos Jara, José Ignacio Chacón, Angels Arcusa, Miguel Gil-Gil, Encarna Adrover, Amparo Oltra, Joan Brunet, Sonia González, Susana Bezares, Virginia Lope, Miguel Martin, Marina Pollán
Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study. Scientific reports 10 (1) (2020)
Miguel Martin, José Angel García-Saenz, Luis Manso Sanchez, Antonio Llombart, Alejo Cassinello, Manuel Atienza, Francois Ringeisen, Eva Ciruelos Gil
Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer. Future oncology (London, England) 16 (33) (2020)
Miguel Martin, S Casla-Barrio, J Alfaro, C Esteban, M A Segui-Palmer, A Lucia, M Martín
Exercise and cancer: a position statement from the Spanish Society of Medical Oncology. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (10) (2020)
Stephen R D Johnston, Nadia Harbeck, Roberto Hegg, Masakazu Toi, Miguel Martin, Zhi Min Shao, Qing Yuan Zhang, Jorge Luis Martinez Rodriguez, Mario Campone, Erika Paige Hamilton, Joohyuk Sohn, Valentina Guarneri, Morihito Okada, Frances Boyle, Patrick Neven, Javier Cortes, Jens Huober, Andrew Wardley, Sara M Tolaney, Irfan Cicin, Ian C Smith, Martin Frenzel, Desirée Headley, Ran Wei, Belen San Antonio, Maarten Hulstijn, Joanne Cox, Joyce O'Shaughnessy, Priya Rastogi, null null
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (34) (2020)
Sara A Hurvitz, Miguel Martin, Michael F Press, David Chan, María Fernandez-Abad, Edgar Petru, Regan Rostorfer, Valentina Guarneri, Chiun-Sheng Huang, Susana Barriga, Sameera Wijayawardana, Manisha Brahmachary, Philip J Ebert, Anwar Hossain, Jiangang Liu, Adam Abel, Amit Aggarwal, Valerie M Jansen, Dennis J Slamon
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Miguel Martín, M J Escudero, Marina Pollan, Miguel Martin, Carlos Jara, Begoña Bermejo, Angel Guerrero-Zotano, José García-Saenz, Ana Santaballa, Emilio Alba, Raquel Andrés, Purificación Martínez, Lourdes Calvo, Antonio Fernández, Norberto Batista, Antonio Llombart-Cussac, Antonio Antón, Ainhara Lahuerta, Juan de la Haba, José Manuel López-Vega, E Carrasco
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry). Scientific reports 9 (1) (2019)
Richard S Finn, Yuan Liu, Zhou Zhu, Miguel Martin, Hope S Rugo, Véronique Diéras, Seock-Ah Im, Karen A Gelmon, Nadia Harbeck, Dongrui R Lu, Eric Gauthier, Cynthia Huang Bartlett, Dennis J Slamon
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (1) (2019)
Manuel Ruíz-Borrego, Angel Guerrero-Zotano, Begoña Bermejo, Manuel Ramos, Josefina Cruz, Jose Manuel Baena-Cañada, Beatriz Cirauqui, Álvaro Rodríguez-Lescure, Emilio Alba, Noelia Martínez-Jáñez, Montserrat Muñoz, Silvia Antolín, Isabel Álvarez, Sonia Del Barco, Elena Sevillano, José Ignacio Chacón, Antonio Antón, María José Escudero, Victoria Ruiz, Eva Carrasco, Miguel Martin, null null
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study. Breast cancer research and treatment 177 (1) (2019)
David E Gerber, Jeffrey R Infante, Michael S Gordon, Sarah B Goldberg, Miguel Martin, Enriqueta Felip, Maria Martinez-García, Joan H Schiller, David R Spigel, Julie Cordova, Valerie Westcott, Yulei Wang, David S Shames, YounJeong Choi, Robert Kahn, Randall C Dere, Divya Samineni, Jian Xu, Kedan Lin, Katie Wood, Stephanie Royer-Joo, Vanessa Lemahieu, Eva Schuth, Anjali Vaze, Daniel Maslyar, Eric W Humke, Howard A Burris
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (2) (2019)
S Pérez Ramírez, M Del Monte-Millán, S López-Tarruella, N Martínez Jáñez, I Márquez-Rodas, F Lobo Samper, Y Izarzugaza Perón, C Rubio Terres, D Rubio Rodríguez, J Á García-Sáenz, F Moreno Antón, P Zamora Auñón, M Arroyo Yustos, M Á Lara Álvarez, E M Ciruelos Gil, L Manso Sánchez, M J Echarri González, J A Guerra Martínez, C Jara Sánchez, C Bueno Muiño, S García Adrián, J R Carrión Galindo, V Valentín Maganto, Miguel Martin
Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (5) (2019)
Virginia Lope, Miguel Martin, Adela Castelló, Amparo Ruiz, Ana Mª Casas, José Manuel Baena-Cañada, Silvia Antolín, Manuel Ramos-Vázquez, José Ángel García-Sáenz, Montserrat Muñoz, Ana Lluch, Ana de Juan-Ferré, Carlos Jara, Pedro Sánchez-Rovira, Antonio Antón, José Ignacio Chacón, Angels Arcusa, Mª Angeles Jimeno, Susana Bezares, Jesús Vioque, Eva Carrasco, Beatriz Perez-Gomez, Marina Pollán
Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study. Scientific reports 9 (1) (2019)
Priyanka Sharma, Miguel Martín, José Angel García-Saenz, Qamar J Khan, Henry L Gómez, Aleix Prat, Fernando Moreno, Yolanda Jerez-Gilarranz, Agusti Barnadas, Antoni C Picornell, María Del Monte-Millán, Milagros González-Rivera, Tatiana Massarrah, Beatriz Pelaez-Lorenzo, María Isabel Palomero, Ricardo González Del Val, Javier Cortés, Hugo Fuentes-Rivera, Denisse Bretel Morales, Iván Márquez-Rodas, Charles M Perou, Carolyn Lehn, Yen Y Wang, Jennifer R Klemp, Joshua V Mammen, Jamie L Wagner, Amanda L Amin, Anne P O'Dea, Jaimie Heldstab, Roy A Jensen, Bruce F Kimler, Andrew K Godwin, Miguel Martin
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (23) (2018)
Daniel D Von Hoff, Drew W Rasco, Elisabeth I Heath, Pamela N Munster, Jan H M Schellens, Nicolas Isambert, Christophe Le Tourneau, Bert O'Neil, Ron H J Mathijssen, Jose Antonio Lopez-Martin, W Jeff Edenfield, Miguel Martin, Patricia M LoRusso, Gordon L Bray, Jorge DiMartino, Aaron Nguyen, Kejian Liu, Eric Laille, Johanna C Bendell
Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (17) (2018)
Miguel Martin, J C de la Torre-Montero, S López-Tarruella, K Pinilla, A Casado, S Fernandez, Y Jerez, J Puente, I Palomero, R González Del Val, M Del Monte-Millan, T Massarrah, C Vila, B García-Paredes, J A García-Sáenz, A Lluch
Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling. Breast cancer research and treatment 171 (3) (2018)
Manuel Ruiz-Borrego, Begoña Jimenez, Silvia Antolín, Jose A García-Saenz, Jesús Corral, Yolanda Jerez, José Trigo, Ander Urruticoechea, Helena Colom, Nuria Gonzalo, Carmen Muñoz, Sara Benito, Rosalía Caballero, Susana Bezares, Eva Carrasco, Federico Rojo, Miguel Martin
A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study. Investigational new drugs 37 (1) (2018)
Milagros Gonzalez-Rivera, Antoni C Picornell, Enrique L Álvarez, Miguel Martin
A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol. JMIR research protocols 5 (3) (2016)